Bayer AG - Annual Report 2006 - Statements of Recognized Income and Expense

Financial Statements

Bayer Group Consolidated Statements of Recognized Income and Expense

	2005	2006
€ million
Changes in fair values of derivatives designated as hedges, recognized in stockholders’ equity	(15)	(59)
Changes in fair values of derivatives designated as hedges, recognized in the income statement	3	11
Changes in fair values of available-for-sale financial assets, recognized in stockholders’ equity	9	(7)
Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits, recognized in stockholders’ equity	(1,207)	448
Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity	857	(725)
Deferred taxes on valuation adjustments offset directly against stockholders’ equity	470	(148)
Deferred taxes on valuation adjustments, removed from stockholders’ equity and recognized in the income statement	-	3
Valuation adjustments recognized directly in stockholders’ equity	117	(477)
Income after taxes	1,595	1,695
Total income and expense recognized in the financial statements	1,712	1,218
of which attributable to minority interest	6	7
of which attributable to Bayer AG stockholders	1,706	1,211